Risk of Recurrence in Patients with HR+/HER2− Early Breast Cancer: A Podcast
Maryam B Lustberg, Megan-Claire Chase, Stacey Tinianov, Kevin Kalinsky · 2026
Read Risk of Recurrence in Patients with HR+/HER2− Early Breast Cancer: A Podcast by Maryam B Lustberg, Megan-Claire Chase, Stacey Tinianov, Kevin Kalinsky (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13631034.txt.
Description
Maryam Lustberg and co-authors discuss the return of early breast cancer in a 2026 podcast piece. For hormone-sensitive, HER2-negative disease, treatment is good but not final: up to twenty-seven percent of patients see the cancer return within twenty years. About half of those returns come within five years, and most returns are metastatic and incurable.
The conversation, joining doctors with a patient advocate, covers how recurrence risk is estimated, how it shifts over time, and what newer treatments offer to cut it. A recurring theme is communication: many patients do not grasp that a return can be distant and incurable, or that the risk exists at all. Bringing the patient voice into the risk talk is presented as part of better shared decisions.
Catalog record
| CREATOR | Maryam B Lustberg, Megan-Claire Chase, Stacey Tinianov, Kevin Kalinsky |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |